SARS-CoV-2 viral liver aggregates and scarce parenchymal infection implicate systemic disease as a driver of abnormal liver function

BACKGROUND: Liver function tests (LFTs) are elevated in >50% of hospitalized individuals infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), with increased enzyme levels correlating with a more severe COVID-19 course. Despite these observations, evaluations of viral presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepe-Mooney, Brian J., Smith, Colton J., Sherman, Marc S., North, Trista E., Padera, Robert F., Goessling, Wolfram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615432/
https://www.ncbi.nlm.nih.gov/pubmed/37889528
http://dx.doi.org/10.1097/HC9.0000000000000290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615432/
https://www.ncbi.nlm.nih.gov/pubmed/37889528
http://dx.doi.org/10.1097/HC9.0000000000000290

Ejemplares similares